LUP Statistics
Record
- Title
- Divergence and convergence of commercial and scientific priorities in drug development: the case of Zelmid, the first SSRI antidepressant
- Type
- Journal Article
- Publ. year
- 2015
- Author/s
- Mulinari, Shai
- Department/s
- Gender Studies
- In LUP since
- 2016-04-01
Downloads
| Total | This Year | This Month |
| 560 | 23 | 1 |
United States of America  |
256 (46%) |
Sweden  |
79 (14%) |
Germany  |
77 (14%) |
China  |
31 (6%) |
United Kingdom of Great Britain and Northern Ireland  |
21 (4%) |
Philippines  |
9 (2%) |
Hong Kong (China)  |
8 (1%) |
Netherlands (Kingdom of the)  |
6 (1%) |
France  |
6 (1%) |
India  |
6 (1%) |
Canada  |
5 (1%) |
Singapore  |
5 (1%) |
Italy  |
4 (1%) |
Russian Federation  |
4 (1%) |
South Korea  |
3 (1%) |
Australia  |
3 (1%) |
Ukraine  |
3 (1%) |
Colombia  |
2 (0%) |
Greece  |
2 (0%) |
Ireland  |
2 (0%) |
Japan  |
2 (0%) |
Cyprus  |
2 (0%) |
Brazil  |
2 (0%) |
Denmark  |
1 (0%) |
Thailand  |
1 (0%) |
United Arab Emirates  |
1 (0%) |
Spain  |
1 (0%) |
Jordan  |
1 (0%) |
Switzerland  |
1 (0%) |
New Zealand  |
1 (0%) |
Sri Lanka  |
1 (0%) |
Bulgaria  |
1 (0%) |
Saudi Arabia  |
1 (0%) |
Egypt  |
1 (0%) |
Bonaire, Sint Eustatius and Saba  |
1 (0%) |
Romania  |
1 (0%) |
Morocco  |
1 (0%) |
Unknown  |
1 (0%) |
Ethiopia  |
1 (0%) |
Viet Nam  |
1 (0%) |
Portugal  |
1 (0%) |
Finland  |
1 (0%) |
Pakistan  |
1 (0%) |
Czechia  |
1 (0%) |
Macedonia  |
1 (0%) |